Partnered Content
As pressure mounts to cut costs, reduce environmental impact, and accelerate development, pharmaceutical innovators are rethinking how medicines are made. A new generation of technologies—flow chemistry, biocatalysis, high-throughput experimentation (HTE), and advanced automation—is reshaping the fu
As the immuno-oncology landscape evolves, developers are facing new challenges in early-phase design, differentiation, and regulatory alignment — all while advancing increasingly complex modalities.
As in vivo CAR-T therapy nears clinical use, researchers and industry leaders explore how it could transform autoimmune disease treatment. Novotech’s Pete Robinson joins Citeline’s Meredith Landry to discuss the science, strategy, and partnerships shaping the future of cell therapy.
Hear experts Matthieu Culié and Alessandro Agosti as they discuss how Olon stands out in a competitive landscape through its fully integrated end-to-end ADC manufacturing expertise, global operations, impurity control and strategic facilities.
Listen now as Citeline speaks with Anil Okay, CEO of Europe’s fast-growing pharma B2B, Adalvo. Learn what the company’s recent acquisition by private equity firm EQT means for both Adalvo and for the industry at large, and find out what trends will be fueling pharma in the years ahead.
Listen now as Citeline speaks with top executives from Perceptive to understand eClinical’s major reset and what it means for the future of clinical trials. Learn more about IRT’s evolving role, lessons learned, and how tech will rule the data-driven trials of the future.
In this exclusive article with Peter Crowley, Secretary and Scientific Director of the BP Commission, you’ll discover how the BP is preparing for its landmark 2026 edition while strengthening its influence as a global bridge between science, regulation, and industry.
Discover how FDA’s C3TI is advancing clinical trials and creating new opportunities to shape the future of drug development.
In this podcast, ICROM CEO Pierfrancesco Morosini and HOLODIAG GM Pierric Marchand explore innovation in HPAPIs, crystallization science, and what it takes to stand out as a modern CDMO.
Community based trials are reshaping clinical research, broadening patient access and accelerating timelines. Discover the drivers, challenges and future outlook.
Key opinion leaders share their perspectives on how transformative technologies like AI will significantly impact the biopharma industry in 2025.
Insights from Novotech on Evolving Trends Impacting Global Clinical Development
Learn how advances in vaccine adjuvants are shaping the future of global health and driving more effective immunization strategies
Insights from Novotech on Evolving Trends Impacting Global Clinical Development
Biotechs focus on novel cancer therapies to address the rising global burden. Yet, oncology R&D poses unique, complex challenges. Overcoming these while adapting to an evolving landscape is key to transforming patient care and improving outcomes.
Discover the latest trends in RNA-based therapeutics and learn how sponsors can successfully navigate the road to next generation innovation. Listen in as Citeline chats with the Director of Therapeutics at Novotech, a CRO experienced in RNA development.
Insights from Novotech on Evolving Trends Impacting Global Clinical Development
Join Andrew Warmington, Manufacturing Editor at Citeline, in conversation with Tom Hickey, Director of Therapeutic Strategy at Novotech, a global full-service clinical CRO dedicated to accelerating the development of advanced and novel therapeutics.
Insights from Novotech on Evolving Trends Impacting Global Clinical Development
Learn about the critical role the right CRO plays in successfully navigating the significant drug development opportunities in Japan.